Aram Kechichian, DO
Procedural Dermatology · Santa Clarita, CANPI 1841241486
Payments from drug & device makers
Across 318 payments — averaging $943.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$205K
- Sanofi US Services Inc.$44K
- Amgen$28K
- E.r. Squibb & Sons, L.L.C.$18K
- Journey Medical Corporation$1K
- UCB, Inc.$1K
- plus $2K from 19 others
Across 1 payment — averaging $2.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2
What the payments were for
- Consulting fees$1,00018%
- Food & beverage$4,47982%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 12 | $204,530 |
| Sanofi US Services Inc. | 10 | $44,201 |
| Amgen | 78 | $28,246 |
| E.r. Squibb & Sons, L.L.C. | 5 | $18,366 |
| Journey Medical Corporation | 5 | $1,066 |
| UCB, Inc. | 66 | $1,045 |
| Johnson & Johnson | 71 | $732 |
| Galderma Laboratories, L.p. | 4 | $299 |
| Sun Pharmaceutical Industries Inc. | 10 | $247 |
| Bristol Myers Squibb | 21 | $212 |
| Pfizer | 7 | $170 |
| Sanofi | 6 | $166 |
| Novartis | 7 | $127 |
| Novo Nordisk | 1 | $106 |
| Almirall LLC | 4 | $96 |
| AbbVie | 1 | $95 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Mayne Pharma Commercial LLC | 1 | $26 |
| Medline Industries LP | 1 | $21 |
| Biofrontera Inc. | 1 | $21 |
| LEO Pharma Inc. | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
| Incyte Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$106
How this compares
$299,913 in reported general payments places this provider in the 90th percentile of 108 procedural dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ArexvyRsvpref3 Antigen/As01e/Pf | 15 | $4,200 |
| Fluocinonide | 78 | $3,538 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 15 | $3,056 |
| Clobetasol Propionate | 41 | $2,111 |
| Ketoconazole | 117 | $1,756 |
| Metronidazole | 14 | $847 |
| Ammonium Lactate | 36 | $729 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 20 | $631 |
| Triamcinolone Acetonide | 80 | $547 |
| Doxycycline Hyclate | 17 | $503 |
| Levocetirizine Dihydrochloride | 25 | $195 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Santa Clarita
- Sabrina FabiSan Diego$6.8M
- Natasha MesinkovskaMission Viejo$4M
- Sam Khalifianla Mesa$3.6M
- Mitchel GoldmanSan Diego$1.5M
- Jeanette BlackLos Angeles$492K
- Suzanne KilmerSacramento$475K
- Rebecca FitzgeraldLos Angeles$324K
- Christopher ZacharyIrvine$269K
- Hrak JalianSanta Monica$243K
- Zakia RahmanStanford$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.